Bette Caan to Risk Assessment
This is a "connection" page, showing publications Bette Caan has written about Risk Assessment.
Connection Strength
1.308
-
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
Score: 0.103
-
Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
Score: 0.098
-
Postdiagnosis Weight Change and Survival Following a Diagnosis of Early-Stage Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):44-50.
Score: 0.096
-
Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.087
-
High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013 May 01; 105(9):616-23.
Score: 0.075
-
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
Score: 0.073
-
Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol. 2012 May 01; 30(13):1492-7.
Score: 0.070
-
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
Score: 0.069
-
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
Score: 0.063
-
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19; 100(22):1581-91.
Score: 0.056
-
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst. 2006 May 17; 98(10):700-7.
Score: 0.047
-
Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
Score: 0.032
-
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
Score: 0.029
-
Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. 2018 06; 154(8):2152-2164.e19.
Score: 0.026
-
Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006 Jul 05; 296(1):79-86.
Score: 0.024
-
Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women. Am J Epidemiol. 2015 Oct 01; 182(7):585-96.
Score: 0.022
-
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015 Aug; 1(5):611-21.
Score: 0.022
-
A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst. 2015 Sep; 107(9).
Score: 0.022
-
Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst. 2014 Jan; 106(1):djt359.
Score: 0.020
-
African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. Am Heart J. 2013 Sep; 166(3):566-72.
Score: 0.019
-
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
Score: 0.019
-
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
Score: 0.016
-
Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer. 2010 Dec 04; 10:670.
Score: 0.016
-
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2011 Jan; 125(2):519-27.
Score: 0.016
-
Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol. 2009 Apr 15; 169(8):977-89.
Score: 0.014
-
Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 2009 May; 58(5):661-7.
Score: 0.013
-
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med. 2008 Mar 18; 148(6):419-26.
Score: 0.013
-
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
Score: 0.013
-
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb; 19(1):61-109.
Score: 0.013
-
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
Score: 0.013
-
Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.
Score: 0.012
-
Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006 Jun 15; 118(12):3140-6.
Score: 0.012
-
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006 May 23; 113(20):2425-34.
Score: 0.012
-
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006 Apr 12; 295(14):1647-57.
Score: 0.012
-
The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control. 2005 Nov; 16(9):1021-33.
Score: 0.011
-
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
Score: 0.011
-
Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1224-9.
Score: 0.011
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
Score: 0.010
-
MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):285-92.
Score: 0.010
-
Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control. 2000 Jan; 11(1):1-8.
Score: 0.008